Esophageal cancer Trials in Beijing, China
Conditions / Esophageal cancer / Beijing, China
Esophageal cancer has been the subject of sustained clinical investigation across multiple research sites.
64 total trials for this combination
Showing top 10 of 64 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06363123 | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | RECRUITING | — |
| NCT05383482 | Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 | COMPLETED | PHASE1/PHASE2 |
| NCT06008054 | A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors | RECRUITING | PHASE2 |
| NCT06238479 | A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors | RECRUITING | PHASE1 |
| NCT02611245 | NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG | COMPLETED | PHASE1 |
| NCT03917043 | APG-2449 in Patients With Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT04014465 | Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer | UNKNOWN | — |
| NCT07410676 | EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT07431281 | Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 | RECRUITING | PHASE3 |
| NCT06469944 | Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06) | RECRUITING | — |